3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
28
Neoplasms, Plasma Cell
9
Neoplasms
7
Lymphoma
6
Leukemia
6
Infections
5
Hematologic Neoplasms
4
Thyroid Carcinoma, Anaplastic
2
Thyroid Cancer, Papillary
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Laryngeal Neoplasms
2
Granuloma, Plasma Cell
2
Glioma
2
Erdheim-Chester Disease
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Sarcoma, Synovial
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Perivascular Epithelioid Cell Neoplasms
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Nephrotic Syndrome
1
Neoplasm Metastasis
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
1
Immunoglobulins
1
Clavulanic Acid
1
Ciprofloxacin
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Agammaglobulinemia
×
Plasma cell
×
Clear all
NCT05678621
2024-04-19
RATIONALISE
Monash University
Phase 2/3
Recruiting
300 enrolled